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Replication of the hepadnavirus genome is catalyzed by a multifunctional reverse transcriptase (the pol protein) that
exhibits DNA polymerase and DNA priming activities and has the ability to transfer RNA and DNA strands across the viral
genome. A salient feature of this enzyme is the ability to prime RNA-directed DNA synthesis with protein rather than with
RNA. This is reflected in its unique physical make up, which includes an amino-terminal (TP) domain that is separated by
a spacer from the reverse transcriptase (RT) domain. To establish a structure–function relationship for the pol protein, we
examined 52 mutants for their ability to replicate viral DNA in vitro and in cultured cells. We demonstrated that the role of
the TP domain is limited to the early steps of viral DNA synthesis including RNA packaging and protein priming. Both the
TP and the RT domains are required for the interaction with epsilon RNA, which is the template for the protein-priming
reaction and serves as the RNA packaging signal. In addition, we report the isolation of a thermosensitive variant of a
hepadnavirus that will permit investigations of individual steps of the viral replication cycle under synchronized conditions.
q 1996 Academic Press, Inc.
INTRODUCTION mechanism substitutes for the strategy used by all other
known retroviral reverse transcriptases, which require
The model for the replication of the hepadnavirus ge-
tRNA as a primer for minus-strand DNA synthesis. Unlike
nome predicts a central role for the viral pol protein in
minus-strand DNA, the polymerase primes plus strands
RNA packaging and DNA synthesis of the viral minus-
with the help of an RNA oligomer derived from the 5*and plus-strand DNAs (Fig. 1) (for a review see Seeger
end of pregenomic RNA (Lien et al., 1987, 1986). The 3*and Mason, 1996). The pol protein is the only known
end of the primer is created by an RNaseH-like activityreverse transcriptase that can prime minus-strand DNA
present on the pol protein (Chang et al., 1990; Radziwillsynthesis de novo through the formation of a covalent
et al., 1990).bond between a nucleotide and a tyrosine residue on
The physical structure of the viral pol protein is un-the pol protein (Bartenschlager and Schaller, 1988; Wang
usual in that it contains an amino-terminal domain,and Seeger, 1992; Weber et al., 1994; Zoulim and Seeger,
termed TP, that is separated by a tether from the actual1994). To prime DNA synthesis, the polymerase must
reverse transcriptase (RT) domain (Sprengel et al., 1985).form a ribonucleoprotein (RNP) complex with an RNA
The TP domain bears the tyrosine residue that servessegment, termed epsilon, located near the 5* end of pre-
as the primer for DNA synthesis and does not sharegenomic (pg) RNA, the template for reverse transcription.
any homology with other known reverse transcriptasesThis interaction also creates a signal for the packaging
(Weber et al., 1994; Zoulim and Seeger, 1994). Geneticof pg RNA and pol protein into core particles that provide
studies indicated that a structurally intact pol protein isthe locale for viral DNA synthesis (Bartenschlager and
required for RNA packaging; i.e., point mutations in eitherSchaller, 1992; Hirsch et al., 1991; Junker-Niepmann et
the TP or the RT domain were shown to inhibit the assem-al., 1990; Pollack and Ganem, 1993). The protein-priming
bly of core particles containing pregenomes (Bar-reaction leads to the synthesis of a short, 3- to 4-nucleo-
tenschlager et al., 1990; Blum et al., 1991; Chang et al.,tide-long DNA strand that remains covalently linked to
1990; Chen et al., 1992, 1994; Hirsch et al., 1990; Roy-the pol protein through a phosphoryltyrosyl bond (Lanford
choudhury et al., 1991). Similarly, studies with in vitro-et al., 1995; Tavis et al., 1994; Wang and Seeger, 1993;
expressed duck hepatitis B virus (DHBV) pol protein indi-Weber et al., 1994; Zoulim and Seeger, 1994). The tem-
cated that neither the TP or the RT domain alone canplate for this reaction is epsilon. To continue DNA synthe-
form an RNP complex with epsilon RNA and supportsis, the polymerase translocates to a position near the
the protein-priming reaction independently of each other3* end of the viral RNA template, which bears sequences
(Pollack and Ganem, 1994; Wang et al., 1994). In addition,for the annealing of the short DNA strand. Thus, this
recent results from our laboratory showed that the forma-
tion of this RNP complex also depends on the presence1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (215) 728-3616; E-mail: C_Seeger@fccc.edu. of the heat shock protein 90 (Hu and Seeger, 1996).
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motif of, at most, five amino acids, are replaced with
alanine. Since clusters of charged amino acids are typi-
cally located on the surface of proteins, substitution of
the respective amino acids with alanine should lead to
only local alterations in an otherwise structurally intact
polypeptide. In support of this theory are observations
previously made with the plasminogen activator, where
over 90% of charged-to-alanine mutants retained the
proper structure (Bennett et al., 1991). Since this ap-
proach has yielded a surprisingly large number of tem-
perature-sensitive mutants with several proteins includ-
ing the poliovirus RNA polymerase (Diamond and Kirke-
gaard, 1994; Hassett and Condit, 1994; Wertman et al.,
1992), we anticipated the isolation of conditional pol pro-
tein variants that would be useful for future investigations
of the viral replication cycle in vitro and in vivo.
MATERIALS AND METHODS
Molecular clones
Plasmid pHP for expression of the DHBV pol protein in
vitro have been described previously (Zoulim and Seeger,
1994). pCMV-DHBV directs expression of the DHBV pre-
genome from the cytomegalovirus immediate-early pro-
moter (Wu et al., 1991).
Mutagenesis
DHBV sequences in plasmid pHP from EcoRI to SalI
were cloned into plasmid pTZ18U (Bio-Rad). Plasmid
FIG. 1. Model for hepadnavirus replication. Relaxed circular virion
DNA was propagated in bacterial strain CJ236 (dut, ung).DNA is converted into covalently closed circular DNA (1), the template
To obtain single-stranded DNA, bacteria were infectedfor transcription of pg RNA. The pol protein binds to the 5* end of pg
RNA to prime minus-strand DNA synthesis (2). Following a template with the helper phage M13K07. Phage DNA was purified
switch to the 3* end of the RNA template, DNA synthesis continues according to the supplier’s protocol. Mutagenesis was
toward the 5* end of pg RNA (3). An RNA oligomer derived from the 5* performed as described in the instruction manual (Bio-
end of pg RNA is transferred to an internal acceptor site on minus-
Rad). Mutations were verified by nucleotide sequencestrand DNA to prime plus-strand DNA synthesis (4). Following the syn-
analysis. The nucleotide sequence of the DNA oligomersthesis of plus strands to the 5* end of minus-strand DNA, a template
switch is required to continue DNA synthesis and the formation of is available upon request.
relaxed circular DNA (5). The pol protein is depicted as a shaded oval. For the RNA-binding assay (see below) an AatII [nt
833 on the DHBV genome (Mandart et al., 1984)] to XhoI
(nt 1213) fragment in variants CA 7 and CA 13 was substi-A major question concerning the functional organiza-
tuted with the corresponding fragment of pHTP that con-tion of the pol protein is how the TP domain contributes
tains an epitope of the influenza hemagglutinin (HA) (Zou-to viral DNA synthesis and whether domains exist on
lim and Seeger, 1994). In variants CA 20, 21, 24, 27, 29,pol that exert specific functions during packaging and
and 31 an AvrII (nt 404) to KpnI (nt 1295) fragment waspriming of minus- and plus-strand DNA synthesis. The
substituted with the corresponding fragment of pHTP.availability of an in vitro pol protein assay provided an
For the construction of plasmids used for the transfectionopportunity to screen a library consisting of more than
of LMH cells, BglII (nt 392) to KpnI (CA 2–15) or XhoI to50 DHBV polymerase variants for protein-priming and
MscI (nt 2373) (CA 16–54) fragments were substitutedepsilon-binding activities. For the mutagenesis of the
for the corresponding fragments in pCMV-DHBV.DHBV pol gene, the so-called ‘‘clustered charged-to-ala-
nine’’ mutagenesis method was selected, which has pre- In vitro priming reaction
viously been employed for genetic analyses of other cel-
lular and viral proteins (Bass et al., 1991; Bennett et al., RNA for the in vitro translation reactions was tran-
scribed from plasmid DNA that was linearized with the1991; Wertman et al., 1992). This approach is based on
an algorithm where two charged amino acids (aspartate, restriction endonuclease AflII (nt 2527) with the Mega-
script kit (Ambion). The pol protein was expressed inglutamate, lysine, or arginine), located within a sequence
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reticulocyte lysates (Promega Biotech) in 10-ml reactions one (CA 14) had only a single amino acid substitution
(Table 1). The target for mutagenesis spanned aminowhich contained [35S]methionine and were supple-
mented with RNA sequences corresponding to epsilon acid positions 106 to 211 in the TP region and amino
acids 363 to 655 in the RT domain (Fig. 2). The selectionRNA, essentially as described previously (Wang et al.,
1994). For the protein-priming reaction, 5 ml of the reticu- of these regions was based, in part, on previous findings
indicating that amino acids 1–74 and 734–785 of the TPlocyte lysate containing the pol protein was incubated
with an equal volume of a solution containing 5 mCi of and RT domains and the spacer region (aa 220–350)
were not required for protein priming in vitro (Wang et[32P]dGTP (800 Ci/mmol), Tris–HCl (100 mM), magne-
sium chloride (4 mM), and sodium chloride (30 mM) for al., 1994).
30 min at 307. Reaction products were separated on
Protein primingSDS–PAGE and dried gels were exposed to two sheets
of X-ray film to monitor the levels of 35S and 32P label The 52 variants were first examined for their ability to
prime DNA synthesis in an in vitro reaction (Fig. 3A).incorporated into the pol protein.
The pol protein polypeptides were translated in a rabbit
RNA-binding assay reticulocyte lysate at 307 and subsequently assayed for
their activity to incorporate radioactively labeled dGTP.The RNA-binding assay was performed as described
From 14 TP variants tested (Table 1, CA 2–15), 12 (86%)previously (Wang et al., 1994). Briefly, the pol protein,
exhibited normal activity in the protein-priming assay,containing an HA epitope in the spacer region, was ex-
whereas 2 (14%) (CA 7 and CA 13) showed significantlypressed in the reticulocyte lysate in the presence of [33P]-
reduced incorporation levels. The activity of CA 7 wasUTP-labeled epsilon RNA. Following the translation reac-
reduced approximately 7-fold and that of CA 13 moretion the pol protein was immunoprecipitated from the
than 10-fold (Fig. 3A, I). From the 38 variants in the RTlysate with a monoclonal antibody specific for the HA
region (Table 1, CA 10–51, CA 53–55), 14 (37%) wereepitope (Babco) and the bound RNA was electropho-
competent for protein priming and 18 (47%) were signifi-resed through a polyacrylamide gel. The gels were dried
cantly impaired. In 6 cases (15%) protein priming couldand exposed to a Fuji phosphoimaging screen for quanti-
not be detected (Fig. 3A, II and III). The mutations in the 6tation.
variants that failed to incorporate dGTP formed a cluster
spanning amino acid residues 394–503, which bearsTissue culture
some of the highly conserved amino acids of reverse
The chicken hepatoma cell line LMH (Kawaguchi et transcriptases, including the catalytic triad (Fig. 2).
al., 1987) was maintained as described by Condreay et The lack of activity of a given variant in the protein-
al. (1990). DNA transfections were carried out with the priming assay could be explained by at least three possi-
help of a calcium phosphate cell transfection kit (5 bilities that include: (i) general misfolding of the mutant
Prime–3 Prime, Inc.). Isolation of viral DNA from protein, (ii) failure to form a functional complex with epsi-
transfected tissue culture cells and Southern blot analy- lon RNA, and (iii) a defect in DNA polymerization. To
sis was done as described previously (Seeger and Mar- distinguish between these three possibilities, we exam-
agos, 1991). ined the potential of variants with impaired protein-prim-
ing activity to form an RNP complex with epsilon RNA.
Packaging assay With the exception of variants CA 13 and CA 29, all other
priming-deficient mutants examined were competent toTotal and core RNA was prepared as described pre-
form a complex with epsilon RNA and, thus, probablyviously (Hu and Seeger, 1996). The levels of viral pg RNA
represented mutants with enzymatic deficiencies due toin total RNA and core RNA preparations from equivalent
local alterations in their polypeptide structures (Fig. 3B).numbers of cells were measured by an RNase protection
In summary, the screening of 52 variants by in vitroassay (RPA II kit, Ambion). The antisense riboprobe used
priming and RNA-binding assays revealed two classeswas 289 nt long with 41 polylinker sequences at the 5*
of mutants: one that failed to bind to epsilon RNA and aend and 248 nt sequences complementary to the DHBV
second that could form an RNP but displayed either nopg RNA, spanning nt 143 to 391 on the DHBV genome.
or reduced protein-priming activity. Mutations of both theThe probe was labeled with [32P]UTP in an in vitro tran-
TP and the RT domains could display these deficiencies,scription reaction.
indicating that joint activities encoded by these two do-
mains are required for binding of epsilon, synthesis ofRESULTS
the first four nucleoties of minus-strand DNA and, by
inference, RNA packaging. This supports previous re-To investigate the role of the TP domain for viral DNA
synthesis and to identify domains on the pol protein that sults obtained with pol protein mutants carrying deletions
at their amino- and carboxyl-termini (Pollack and Ganem,are required for RNA packaging and priming of minus-
and plus-strand DNA, we created 52 mutants, of which 1994; Wang et al., 1994).
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TABLE 1
pol Protein Mutants
aa residue to DNA-priming RNA-binding DNA RNA
Mutant alanine change activity activity replication packaging
CA 2 E106, K108 ///a NDb /// ND
CA 3 K108, D111 /// ND /// ND
CA 4 D111, D114 /// ND /// ND
CA 5 D120, E124 /// ND /// ND
CA 6 E124, R128 /// ND 0 //(20%)c
CA 7 R128, K131 / /// //0 //(14%)
CA 8 K137, K141 /// ND // ND
CA 9 K153, K155 /// ND /// ND
CA 10 K155, D158 /// ND /// ND
CA 11 K169, R173 /// ND /// ND
CA 12 R173, E176 /// ND / ND
CA 13 K182, R183 //0 //0 ND / (2%)
CA 14 K186 /// ND // ND
CA 15 Y210, D211 /// ND /// ND
CA 16 D363, K364 // ND ND ND
CA 17 E369, E370 /// ND /// ND
CA 18 E370, E371 // ND ND ND
CA 19 R385, K389 / ND ND ND
CA 20 D394, K395 0 // ND ND
CA 21 K395, R398 0 // ND ND
CA 22 E401, E402 /// ND // ND
CA 24 R404, D408 0 /// ND ND
CA 25 K414, K416 / ND ND ND
CA 26 R420, R423 /// ND // ND
CA 27 R442, D446 0 /// ND ND
CA 28 D478, R481 /// ND /// ND
CA 29 R486, K487 0 //0 ND //(13%)
CA 30 E499, R502 /// ND /// ND
CA 31 R502, R503 0 / ND ND
CA 32 E538, R542 // ND / ND
CA 33 R542, D546 /// ND ND ND
CA 34 D546, K547 /// ND /d(ts) ///
CA 35 E555, R557 /// ND /// ND
CA 36 D564, E565 /// ND //(ts) ND
CA 37 E565, K569 // ND ND ND
CA 38 K569, E571 / ND ND ND
CA 39 E571, E572 // ND ND ND
CA 40 E572, R574 / ND ND ND
CA 41 R574, K576 /// ND /// ND
CA 42 K576, E577 / ND ND ND
CA 43 E577, R579 // ND ND ND
CA 44 R579, K583 /// ND / ND
CA 45 K583, K584 / ND ND ND
CA 46 K584, K586 /// ND // ND
CA 47 K586, E589 // ND ND ND
CA 48 E589, D592 / ND ND ND
CA 49 D592, K594 // ND ND ND
CA 50 K594, R598 // ND ND ND
CA 51 K611, E615 /// ND ///(ts) ///
CA 53 K649, R651 // ND ND ND
CA 54 R651, K653 /// ND /// ND
CA 55 K653, K655 // ND ND ND
a ///, 30–100% of wild-type activity, //, 10–30%; /, 1–10%, 0, 1%.
b ND, not done; ts, temperature sensitive.
c % of wild-type RNA packaging activity.
d Incomplete DNA synthesis.
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FIG. 2. Location of the CA mutations on the physical map of the DHBV pol protein. The positions of the mutations in the CA variants are shown.
Mutants with a more than 10-fold deficiency in protein priming in vitro or DNA replication in cells are marked with black boxes. Mutants with greater
than 10-fold reductions in DNA synthesis are marked with gray boxes. Mutants with a temperature-sensitive phenotype in cell cultures are marked
with a white box. For details see Table 1. Amino acid residues that are conserved among pol proteins of other retroviruses are indicated. The
approximate positions of the predicted finger, palm, thumb, and connector (black rectangle) domains of the RT based on amino acid homologies
between the HIV-1 RT (Jacobo-Molina et al., 1993; Kohlstaedt et al., 1992) and the DHBV pol protein are shown at the bottom.
Replication in LMH cells the synthesis of minus- and plus-strand DNAs, a total of
27 pol protein mutants (13 in the TP and 14 in the RT
To identify pol protein variants with defects in steps
domains) were examined for their ability to support viral
that occur during RNA packaging or subsequently during
DNA replication in the hepatoma cell line LMH (Table 1,
column 5). All variants, save for CA 7, exhibited a wild-
type phenotype in the in vitro protein-priming reaction. To
identify temperature-sensitive mutants, the transfected
cells were incubated at 33 and 39 or 40.57. Three to five
days after transfection, replicative DNA intermediates
were isolated from subviral core particles present in the
cytoplasm of the transfected cells and analyzed by South-
ern blot analysis (Fig. 4).
The analysis of the TP variants at 337 revealed 8/13
(62%) mutants with a wild-type phenotype, 3/13 (23%) with
significantly reduced levels, and 2/13 (15%) with barely
detectable (CA 7) or undetectable (CA 6) levels of DNA
synthesis (Table 1; Figs. 4A and 4B). While the result
obtained with CA 7 reflected the observations made in
vitro with this mutant, the results obtained with the other
four variants (CA 6, CA 8, CA 12, CA 14) showed that
these variants exhibited a defect in vivo that was not
apparent in vitro.
The results obtained with the RT mutants showed that
at 337 7/13 (54%) replicated DNA at normal levels,
whereas 5/13 (38%) had reduced levels and 1/13 (8%)
was deficient in the synthesis of complete viral DNA (CA
FIG. 3. Protein-priming and RNA-binding reactions of CA mutants. 34). CA 34 synthesized short DNA strands that repre-
(A) Results from the protein-priming assay with CA mutants in the TP sented nascent minus-strand DNA (Table 1; Fig. 4C).
(I) and RT (II and III) regions. (B) Levels of [33P]UTP-labeled epsilon When DNA was extracted from cells that were incu-RNA recovered following immunoprecipitation of wild-type (WT) and
bated at 39 or 40.57, we observed that wild-type virusmutant (CA) pol proteins expressed in the reticulocyte lysate (see Mate-
rial and Methods). replicated two- to threefold lower compared to replication
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were incapable of binding epsilon RNA in vitro (Fig. 3B)
and, therefore, were expected to be defective for RNA
packaging in vivo. Also included was mutant CA 7, which
could bind to epsilon RNA in vitro (results not shown)
but replicated viral DNA at markedly reduced levels in
transfected cells (Figs. 3A and 4A). While the ratio of
packaged (C) to total cytoplasmic RNA (T) in cells
transfected with wild-type virus was approximately 1:1,
the ratio in CA 13 was significantly reduced to 1:50, re-
flecting an inability of this variant to encapsidate pg RNA.
In CA 29 the C:T ratio was reduced only to 1:8, which
may indicate that a second packaging signal previously
identified on the DHBV genome can partially overcome
the deficiency of certain pol protein mutants to bind to
epsilon RNA (Calvert and Summers, 1994; Hirsch et al.,
1991). RNA packaging in mutants CA 6 and CA 7 was
reduced to similar levels as observed with CA 29 with
C:T ratios of 1:5 and 1:7, respectively, indicating that both
variants exhibited a defect in RNA packaging. However,
since DNA replication was detectable with CA 7 but not
with CA 6, the results from the packaging assay sug-
gested the existence of additional defects during minus-
strand DNA synthesis in the pol protein of CA 6.FIG. 4. Replication of CA mutants in LMH cells. DHBV DNA present
In summary, the screening of 52 variants in tissuein core particles isolated from LMH cells transfected with the indicated
plasmid DNAs. The position of relaxed circular (RC), double-stranded culture revealed mutants that can bind epsilon RNA in
linear (DLS), and single-stranded (SS) DNA species characteristic of vitro but display reduced packaging activity in vivo and
hepadnavirus replication are indicated. Transfected LMH cells were are deficient for DNA synthesis (CA 6, CA 7) and a variant
maintained at 337 (L) and at (A and B) 397 (H) or (C and D) 407 (H).
that is defective for complete minus- and plus-strand
DNA synthesis (CA 34). In addition we discovered three
mutants with a temperature-sensitive phenotype.at 337 (Fig. 4A). Furthermore, the accumulation of incom-
plete DNA strands appeared to be reduced at higher
temperatures, most notably when cells were kept at 40.57 The temperature-sensitive nature of the CA 51 pol
(Figs. 4C and 4D). In consideration of these observations, protein
we identified variants CA 34, CA 36, and CA 51, all of
which had mutations in the RT domain, as at least fivefold To investigate whether the pol protein encoded by mu-
tant CA 51 was thermosensitive for protein priming, RNAmore thermosensitive than wildtype (Figs. 4B–4D). The
most striking effect was observed with variant CA 51, packaging, or DNA polymerization, we examined the variant
both in vitro and in cultured cells. The results of the protein-which displayed a wild-type phenotype at the lower tem-
perature but appeared to be completely defective for priming assay showed that CA 51 did not exhibit a condi-
tional phenotype in vitro (results not shown) and, thus, sug-DNA synthesis at the elevated temperature (Fig. 4D).
So far, our results showed that, with the exception of gested that the mutation inhibited RNA packaging or DNA
synthesis. To distinguish between the two possibilities, wevariants CA 6 and CA 34, all mutants examined were
competent for the synthesis of virion DNA; i.e., we did measured the levels of packaged pg RNA in transfected
cells at 33.6 and 397. Our results showed that the T:C rationot identify any pol protein variants with a specific defect
in plus-strand DNA synthesis. The phenotype of CA 6 was not significantly affected by temperature (Fig. 5B) and
invoked the hypothesis that DNA elongation was impairedsuggested that the observed defect could have affected
an early step of the DNA replication cycle, presumably at elevated temperatures (Fig. 5B). To directly confirm this
notion, we assayed the variant under the conditions dia-following RNA packaging and protein priming. Since pro-
tein priming per se cannot be measured in cell cultures, grammed in Fig. 6A. Transfected LMH were maintained
at the permissive temperature (33.67) in the presence ofwe investigated whether pg RNA expressed with CA 6
is packaged into viral cores at 337. The RNA packaging foscarnet (PFA), a pyrophosphate analogue and known re-
versible inhibitor of the DHBV pol protein, for 4 days (Fig.assay is based on the observation that in contrast to
unpackaged RNA, encapsidated pg RNA is protected 6A). When PFA was removed from the medium, DNA repli-
cation ensued within a few hours in a synchronized fashionfrom digestion with microccocal nuclease (Lavine et al.,
1989; Schlicht et al., 1989). As negative controls for this (Fig. 6B, lanes 4–6). The appearance of short DNA strands
representing nascent minus-strand DNA was followed byexperiment we used variants CA 13 and CA 29, which
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of the viral pol protein polypeptide during DNA replica-
tion. This analysis was facilitated through the availability
of a rapid in vitro screening assay that permitted the
identification of selected variants that could subse-
quently be tested in a more labor-intensive tissue culture
system. A limitation of our study was that it did not in-
clude an assay for infectivity of certain variants in primary
hepatocyte cultures and even in ducklings. However, re-
sults from such an analysis would have been difficult to
interpret since mutations in the pol protein open reading
FIG. 5. Packaging of pg RNA into core particles. RNase protection frame can also alter the overlapping envelope genes and
assay of total and encapsidated pg RNA extracted from DHBV- possibly interfere with transcriptional elements that are
transfected LMH cells. T, total RNA; C, core (encapsidated) RNA. The
superimposed onto the pol protein gene. Nevertheless,position of the 248-nt-long protected RNA species is indicated by an
as discussed below, with the analysis of 52 variants, wearrow.
have established a detailed structure–function map of
the TP and RT domains and identified the first tempera-
the appearance of the complete single-stranded minus ture-sensitive mutant of a hepadnavirus.
strands and relaxed circular DNA, which accumulate in
hepatocytes during a natural hepadnavirus infection (Fig. Function of the TP domain
6B, lanes 5 and 6). Unexpectedly, when cells were placed
Previous genetic and biochemical studies of the DHBV
at 397 following the removal of PFA, viral DNA was also
pol protein showed that the TP domain is critical for the
synthesized, which indicated that the pol protein translated
protein-priming reaction since it contains the tyrosine
at the permissive temperature could elongate DNA under
residue linked to the 5* end of minus-strand DNA (Weber
‘‘nonpermissive’’ conditions (lane 7). In contrast, when cells
et al., 1994; Zoulim and Seeger, 1994). Thus, the unique
were shifted directly from the elevated to the permissive
mechanism for initiation of hepadnaviral DNA synthesis
temperature, but without an incubation period with PFA at
appears to be imprinted on the physical structure of the
the lower temperature, DNA replication occurred with a
viral pol protein gene. Consistent with a role for TP do-
delay of at least 10 hr and was not synchronized (Fig. 6B,
main for the protein-priming reaction is the identification
compare lanes 4–6 and 8–10), suggesting that de novo
of variant CA 13 which failed to bind to epsilon RNA. One
synthesis of the polymerase had to occur at 337 and that
of the two mutated amino acids in CA 13 mapped to
pol protein made at 397 was not functional for DNA elonga-
an arginine residue (R 183) that is conserved among
tion even when assayed at the permissive temperature.
hepadnavirus pol proteins. Consistent with our observa-
tion, a mutation corresponding to R 183 in HBV was
DISCUSSION
previously shown to inhibit packaging of pg RNA (Roy-
choudhury et al., 1991). Furthermore, Blum and col-The purpose of this genetic analysis of a hepadnavirus
pol protein was to assign functions to specific domains leagues (Blum et al., 1991) identified a variant of HBV
FIG. 6. Temperature-dependent DNA replication of CA 51. (A) Outline of the protocol used for the analysis of DNA synthesis by mutant CA 51 in
LMH cells. The numbers correspond to the lanes shown in B. (B) The results from Southern blot analysis of DHBV DNA isolated from cores present
in LMH cells transfected with CA 51 plasmid DNA. Lane 1, 200 pg of DHBV-containing plasmid DNA; lanes 2 and 3, DHBV DNA isolated from LMH
cells maintained at 33 and 397, respectively; lanes 4–11, see A. PFA, foscarnet.
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with a single missense mutation located two amino acids variants examined exhibited no apparent qualitative de-
fect in viral DNA synthesis. As with the TP mutants, wedownstream of this arginine residue that also prevented
RNA packaging. It thus appears that the region sur- did not observe any variants that failed to prime and
elongate plus-strand DNA. It thus appears that the reac-rounding R 183 is critical for the interaction of the pol
protein with epsilon RNA both in DHBV and in HBV. In tions leading to plus-strand DNA synthesis all depend
on functions required for minus-strand DNA synthesiscontrast to CA 13, variant CA 6 appeared to be functional
for RNP formation and protein priming in vitro but pack- including the strand transfer of the RNA primer for plus-
strand DNA synthesis (Fig. 1, step 5). Naturally, an excep-aged pg RNA at reduced levels in vivo and completely
failed to replicate viral DNA in cell culture. It is possible tion are mutations that affect the RNaseH activity, which
can lead to a specific defect in plus-strand DNA synthe-that CA 6 was defective for the translocation reaction
required for the continuation of minus-strand DNA syn- sis (Chen et al., 1992; Radziwill et al., 1990). Variant CA
34 appeared to be defective in elongation of completethesis following the protein-priming reaction (Fig. 1, step
3). However, other possibilities, such as the failure of the minus strands, which could be explained by a defect
in processivity of the polymerase or, alternatively, by avariant to correctly assemble with core subunits, cannot
be excluded. Consistent with a primary role for the TP reduced RNaseH activity. The latter possibility could be
explained by an aberrant interaction between polymer-region during early steps of viral replication (Fig. 1, steps
2 and 3), we did not identify TP variants with detectable ase and RNAseH domains as discussed previously by
Chang and colleagues (Chang et al., 1990).defects in elongation of minus and plus strands or prim-
ing of plus-strand DNA. Furthermore, the TP variants that
were competent for viral DNA synthesis appeared to be Thermosensitive variants
competent for the formation of covalently closed circular
DNA (results not shown). As previously reported by others who used the
‘‘charged amino acid to alanine’’ algorithm for mutagene-
sis, we have also identified some variants with a condi-Function of the RT domain
tional phenotype (Diamond and Kirkegaard, 1994; Has-
sett and Condit, 1994). While several mutants displayedBased on amino acid sequence comparisons with ret-
roviral pol proteins, the RT regions of hepadnavirus pol a slightly reduced protein-priming activity in vitro at ele-
vated temperatures (results not shown), we found threeproteins can be divided into DNA polymerase and RNA-
seH domains (Radziwill et al., 1990; Toh et al., 1983). Our variants that exhibited a significant difference in DNA
replication levels in cell cultures depending on the tem-analysis of variants in the RT region yielded primarily
phenotypes with reduced or absent protein-priming activ- perature conditions (Table 1; Figs. 4C and 4D). The most
interesting mutant, CA 51, appeared to be very tight inity (Table 1), which concurs well with the expected role
of this domain in DNA synthesis. Inferring from the known that DNA replication was normal at 337 but not detectable
at 40.57. The defect of this variant could not be detectedstructure of the HIV-1 RT, the conserved residues K 395,
D 446, and DD 513/514 lie in the active site of the pol in vitro and appeared to be on a step subsequent to
RNA packaging in vivo, indicating that RNP formationprotein and as shown previously and in this study are
essential for pol protein activity (Chang et al., 1990; Ja- and protein priming were most likely not impaired by
the mutation. Furthermore, pol protein expressed at thecobo-Molina et al., 1993; Kohlstaedt et al., 1992). Of par-
ticular interest to this study was variant CA 29, which permissive temperature could elongate DNA under non-
permissive conditions. Based on amino acid sequencelost the ability to form an RNP and thus exhibited the
same phenotype described for the TP variant CA 13. comparisons with the HIV-1 RT, the mutation in CA 51
would be located in the thumb region that is importantThis result suggested that RNP formation either requires
binding of the RNA to two separate domains on the pol for the arrangement of the template primer (Jacobo-Mol-
ina et al., 1993; Kohlstaedt et al., 1992) (Fig. 2). One likelyprotein or, alternatively, that an interaction between the
TP and the RT domains are required for this reaction. explanation for these observations is that expression of
the RT of CA 51 at elevated temperatures leads to aLike CA 13, CA 29 carries a mutation in an arginine
residue (R 486) that is conserved among hepadnaviral locally misfolded protein that cannot execute the transfer
of nascent minus strands across pg RNA. It is conceiv-pol proteins. Although CA 29 failed to form a stable RNP
in vitro (Fig. 3B), it appeared to package pg RNA, albeit able that this transfer reaction depends on a conforma-
tional change in the RT domain that cannot occur with CAwith a reduced efficiency. It is possible that packaging
in CA 29 is triggered by the activity of a second packaging 51 expressed at the elevated temperature. Alternatively, it
cannot be ruled out that the defect abrogates the abilitysignal on the DHBV genome located downstream of epsi-
lon RNA (Calvert and Summers, 1994; Hirsch et al., 1991), of the pol protein to elongate minus-strand DNA. What-
ever the nature of the defect is, this variant will be valu-which could function independently of the interaction be-
tween the pol protein and epsilon RNA. able for the establishment of a tissue culture system
for synchronized replication of DHBV. It will permit theWith the exception of variant CA 34 (Fig. 4C), all other
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